Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.220
+0.050 (1.20%)
At close: Jan 16, 2026, 4:00 PM EST
4.280
+0.060 (1.42%)
After-hours: Jan 16, 2026, 7:00 PM EST
Orchestra BioMed Holdings Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$14.25
Upside
+237.68%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $11 → $12 | Buy | Maintains | $11 → $12 | +184.36% | Jan 9, 2026 |
| TD Cowen | TD Cowen | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +255.45% | Dec 10, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +373.93% | Nov 13, 2025 |
| Barclays | Barclays | Buy Maintains $12 → $11 | Buy | Maintains | $12 → $11 | +160.66% | Nov 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +136.97% | Sep 4, 2025 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 20, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +373.93% | Aug 13, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +373.93% | Aug 7, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +373.93% | May 13, 2025 |
| Barclays | Barclays | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | +184.36% | May 5, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +373.93% | Apr 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +184.36% | Apr 4, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +373.93% | Apr 1, 2025 |
| BTIG | BTIG | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +184.36% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +231.75% | Mar 10, 2025 |
| Barclays | Barclays | Buy Initiates $16 | Buy | Initiates | $16 | +279.15% | Jan 2, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.